Johnson & Johnson JNJ
NYSE JNJ
$263.85 -3.83 (-1.43%)
At close: Oct 23, 2026 · 4:00 PM EDT

Johnson & Johnson (JNJ) Cash from Operations (2009 - 2026)

Updated

Johnson & Johnson's Cash from Operations came in at $7.72 billion for Q3 2026, down 15.8% from $9.17 billion a year earlier and down 10.4% from the prior quarter.

Analysis

Johnson & Johnson (JNJ) Cash from Operations (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 27, 2026, Johnson & Johnson reported Cash from Operations of $26.16 billion, up 8.1% year-over-year; for FY2025, it was $24.53 billion, up 1.1% from FY2024.

  • Cash from Operations has increased in each of the last three years, with a four-year compound annual growth rate of 1.0% (FY2021 to FY2025).
  • Going back by year, Cash from Operations was $24.27 billion in FY2024 (+6.5%), $22.79 billion in FY2023 (+7.5%), $21.19 billion in FY2022 and $23.54 billion in FY2021.
  • The five-year range for quarterly Cash from Operations is $2.51 billion (Q1 2026) to $9.17 billion (Q3 2025).
  • Year-over-year, Cash from Operations increased in four of the last eight quarters, with growth averaging 7.2%.
  • The fastest year-over-year change in Cash from Operations over five years came in Q4 2023 (growth of 123.6%), and the weakest in Q1 2026 (a decline of 39.8%).
  • Business Quant data shows JNJ's Cash from Operations at $8.62 billion (Q2 2026), $2.51 billion (Q1 2026) and $7.31 billion (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 10.69 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 7.72 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 3.44 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 5.37 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 5.88 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 2.87 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 4.00 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 3.57 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 835.00 Mn
10 Vertex Pharmaceuticals 132.74 Bn 104.74 Bn 2.84 Bn 1.13 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 27, 2026 7.72 Bn
Jun 28, 2026 8.62 Bn
Mar 29, 2026 2.51 Bn
Dec 28, 2025 7.31 Bn
Sep 28, 2025 9.17 Bn
Jun 29, 2025 3.88 Bn
Mar 30, 2025 4.17 Bn
Dec 29, 2024 6.98 Bn
Sep 29, 2024 7.99 Bn
Jun 30, 2024 5.63 Bn
Mar 31, 2024 3.66 Bn
Dec 31, 2023 7.86 Bn
Oct 1, 2023 7.49 Bn
Jul 2, 2023 4.18 Bn
Apr 2, 2023 3.26 Bn
Jan 1, 2023 3.52 Bn
Apr 3, 2022 3.98 Bn
Oct 3, 2021 8.29 Bn
Jul 4, 2021 5.31 Bn
Apr 4, 2021 4.07 Bn
API Access

Johnson & Johnson Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=JNJ&period=max&api_key=YOUR_API_KEY